Specific overexpression of cyclin E·CDK2 in early preinvasive and primary breast tumors in female aci rats induced by estrogen

Saravut (John) Weroha, Wilma L. Lingle, Yan Hong, Sara Antonia Li, Jonathan J. Li

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Overexpressed Aurora A, amplified centrosomes, and aneuploidy are salient features of estrogen-induced mammary preinvasive lesions and tumors in female August-Copenhagen Irish (ACI) rats. Intimately involved in these events are cyclins and their associated cyclin- dependent kinase (CDK) partners. Cyclin E1·CDK2 over-expression plays an important dual role in late G1/S phase of the cell cycle in cancer cells. It increases DNA replication providing growth advantage to cancer cells and facilitates aberrant centrosome duplication, generating chromosomal instability and aneuploidy leading to tumor development. Presented herein, a 24.0- and 45.0-fold elevation in cyclin E1 and CDK2 was found in 17β-estradiol (E 2)-induced ACI rat mammary tumors (MTs), respectively. Cyclin E·CDK2 positive staining was confined to the large round cells found within focal dysplasias, ductal carcinomas in situ, and invasive MTs. Co-immunoprecipitation and in vitro kinase activity of these tumors revealed that these cell cycle entities are functional. When mammary tissue derived from untreated normal, E 2-induced hyperplasia and primary tumors were normalized to cyclin E1 levels, low molecular weight (LMW) cyclin E1 forms (33- and 45-kDa) were detected in all of these tissue groups. Moreover, increasing concentrations of protease inhibitor in tissue lysates resulted in a marked reduction of LMW forms, indicating that the presence of cyclin E1 LMW forms can be markedly reduced. Significant increases in cyclin E1 mRNA (2.1-fold) were detected in primary ACI rat E 2-induced breast tumors, and quantitative real-time polymerase chain reaction revealed a 20% amplification of the cyclin E1 gene (CCNE1). Collectively, these results support the involvement of cyclin E1·CDK2 in centrosome overduplication during each stage of E 2-induced mammary tumorigenesis.

Original languageEnglish (US)
Pages (from-to)34-43
Number of pages10
JournalHormones and Cancer
Volume1
Issue number1
DOIs
StatePublished - Feb 2010

Fingerprint

Cyclins
Estrogens
Breast Neoplasms
Centrosome
Neoplasms
Breast
Molecular Weight
Aneuploidy
Cell Cycle
Chromosomal Instability
Carcinoma, Intraductal, Noninfiltrating
Cyclin-Dependent Kinases
G1 Phase
Protease Inhibitors
DNA Replication
S Phase
Immunoprecipitation
Hyperplasia
Real-Time Polymerase Chain Reaction
Estradiol

Keywords

  • Aci rat
  • Breast cancer
  • Cyclin E1·CDK2
  • Estrogen

ASJC Scopus subject areas

  • Oncology
  • Cancer Research
  • Endocrinology
  • Endocrinology, Diabetes and Metabolism
  • Endocrine and Autonomic Systems

Cite this

Specific overexpression of cyclin E·CDK2 in early preinvasive and primary breast tumors in female aci rats induced by estrogen. / Weroha, Saravut (John); Lingle, Wilma L.; Hong, Yan; Li, Sara Antonia; Li, Jonathan J.

In: Hormones and Cancer, Vol. 1, No. 1, 02.2010, p. 34-43.

Research output: Contribution to journalArticle

@article{d5342fc321384d5a934ed79743fee37e,
title = "Specific overexpression of cyclin E·CDK2 in early preinvasive and primary breast tumors in female aci rats induced by estrogen",
abstract = "Overexpressed Aurora A, amplified centrosomes, and aneuploidy are salient features of estrogen-induced mammary preinvasive lesions and tumors in female August-Copenhagen Irish (ACI) rats. Intimately involved in these events are cyclins and their associated cyclin- dependent kinase (CDK) partners. Cyclin E1·CDK2 over-expression plays an important dual role in late G1/S phase of the cell cycle in cancer cells. It increases DNA replication providing growth advantage to cancer cells and facilitates aberrant centrosome duplication, generating chromosomal instability and aneuploidy leading to tumor development. Presented herein, a 24.0- and 45.0-fold elevation in cyclin E1 and CDK2 was found in 17β-estradiol (E 2)-induced ACI rat mammary tumors (MTs), respectively. Cyclin E·CDK2 positive staining was confined to the large round cells found within focal dysplasias, ductal carcinomas in situ, and invasive MTs. Co-immunoprecipitation and in vitro kinase activity of these tumors revealed that these cell cycle entities are functional. When mammary tissue derived from untreated normal, E 2-induced hyperplasia and primary tumors were normalized to cyclin E1 levels, low molecular weight (LMW) cyclin E1 forms (33- and 45-kDa) were detected in all of these tissue groups. Moreover, increasing concentrations of protease inhibitor in tissue lysates resulted in a marked reduction of LMW forms, indicating that the presence of cyclin E1 LMW forms can be markedly reduced. Significant increases in cyclin E1 mRNA (2.1-fold) were detected in primary ACI rat E 2-induced breast tumors, and quantitative real-time polymerase chain reaction revealed a 20{\%} amplification of the cyclin E1 gene (CCNE1). Collectively, these results support the involvement of cyclin E1·CDK2 in centrosome overduplication during each stage of E 2-induced mammary tumorigenesis.",
keywords = "Aci rat, Breast cancer, Cyclin E1·CDK2, Estrogen",
author = "Weroha, {Saravut (John)} and Lingle, {Wilma L.} and Yan Hong and Li, {Sara Antonia} and Li, {Jonathan J.}",
year = "2010",
month = "2",
doi = "10.1007/s12672-009-0004-z",
language = "English (US)",
volume = "1",
pages = "34--43",
journal = "Hormones and Cancer",
issn = "1868-8497",
publisher = "Springer US",
number = "1",

}

TY - JOUR

T1 - Specific overexpression of cyclin E·CDK2 in early preinvasive and primary breast tumors in female aci rats induced by estrogen

AU - Weroha, Saravut (John)

AU - Lingle, Wilma L.

AU - Hong, Yan

AU - Li, Sara Antonia

AU - Li, Jonathan J.

PY - 2010/2

Y1 - 2010/2

N2 - Overexpressed Aurora A, amplified centrosomes, and aneuploidy are salient features of estrogen-induced mammary preinvasive lesions and tumors in female August-Copenhagen Irish (ACI) rats. Intimately involved in these events are cyclins and their associated cyclin- dependent kinase (CDK) partners. Cyclin E1·CDK2 over-expression plays an important dual role in late G1/S phase of the cell cycle in cancer cells. It increases DNA replication providing growth advantage to cancer cells and facilitates aberrant centrosome duplication, generating chromosomal instability and aneuploidy leading to tumor development. Presented herein, a 24.0- and 45.0-fold elevation in cyclin E1 and CDK2 was found in 17β-estradiol (E 2)-induced ACI rat mammary tumors (MTs), respectively. Cyclin E·CDK2 positive staining was confined to the large round cells found within focal dysplasias, ductal carcinomas in situ, and invasive MTs. Co-immunoprecipitation and in vitro kinase activity of these tumors revealed that these cell cycle entities are functional. When mammary tissue derived from untreated normal, E 2-induced hyperplasia and primary tumors were normalized to cyclin E1 levels, low molecular weight (LMW) cyclin E1 forms (33- and 45-kDa) were detected in all of these tissue groups. Moreover, increasing concentrations of protease inhibitor in tissue lysates resulted in a marked reduction of LMW forms, indicating that the presence of cyclin E1 LMW forms can be markedly reduced. Significant increases in cyclin E1 mRNA (2.1-fold) were detected in primary ACI rat E 2-induced breast tumors, and quantitative real-time polymerase chain reaction revealed a 20% amplification of the cyclin E1 gene (CCNE1). Collectively, these results support the involvement of cyclin E1·CDK2 in centrosome overduplication during each stage of E 2-induced mammary tumorigenesis.

AB - Overexpressed Aurora A, amplified centrosomes, and aneuploidy are salient features of estrogen-induced mammary preinvasive lesions and tumors in female August-Copenhagen Irish (ACI) rats. Intimately involved in these events are cyclins and their associated cyclin- dependent kinase (CDK) partners. Cyclin E1·CDK2 over-expression plays an important dual role in late G1/S phase of the cell cycle in cancer cells. It increases DNA replication providing growth advantage to cancer cells and facilitates aberrant centrosome duplication, generating chromosomal instability and aneuploidy leading to tumor development. Presented herein, a 24.0- and 45.0-fold elevation in cyclin E1 and CDK2 was found in 17β-estradiol (E 2)-induced ACI rat mammary tumors (MTs), respectively. Cyclin E·CDK2 positive staining was confined to the large round cells found within focal dysplasias, ductal carcinomas in situ, and invasive MTs. Co-immunoprecipitation and in vitro kinase activity of these tumors revealed that these cell cycle entities are functional. When mammary tissue derived from untreated normal, E 2-induced hyperplasia and primary tumors were normalized to cyclin E1 levels, low molecular weight (LMW) cyclin E1 forms (33- and 45-kDa) were detected in all of these tissue groups. Moreover, increasing concentrations of protease inhibitor in tissue lysates resulted in a marked reduction of LMW forms, indicating that the presence of cyclin E1 LMW forms can be markedly reduced. Significant increases in cyclin E1 mRNA (2.1-fold) were detected in primary ACI rat E 2-induced breast tumors, and quantitative real-time polymerase chain reaction revealed a 20% amplification of the cyclin E1 gene (CCNE1). Collectively, these results support the involvement of cyclin E1·CDK2 in centrosome overduplication during each stage of E 2-induced mammary tumorigenesis.

KW - Aci rat

KW - Breast cancer

KW - Cyclin E1·CDK2

KW - Estrogen

UR - http://www.scopus.com/inward/record.url?scp=78650202724&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78650202724&partnerID=8YFLogxK

U2 - 10.1007/s12672-009-0004-z

DO - 10.1007/s12672-009-0004-z

M3 - Article

VL - 1

SP - 34

EP - 43

JO - Hormones and Cancer

JF - Hormones and Cancer

SN - 1868-8497

IS - 1

ER -